154 Reference | Support Invivoscribe 2019 | 155 Reference Support Poster Abstracts Genetic Heterogeneity and Stratification of AML Samples with NPM1 Mutation Detected by the MyAML® NGS Test Poster presented at: Association for Molecular Pathology 2017 Annual Meeting. 2017 November 16-18, Salt Lake City, UT, USA. Clonality Detection Using Next-Generation Sequencing and Capillary Electrophoresis Methods in Suspect Lymphoproliferative Samples Poster presented at: Association for Molecular Pathology 2017 Annual Meeting. 2017 November 16-18, Salt Lake City, UT, USA. Validation of the LeukoStrat® CDx FLT3 Mutation Assay: Used to Detect both Internal Tandem Duplication (ITD) and Tyrosine Kinase Domain (TKD) Mutations and Response to Midostaurin in 1058 Patients with AML Poster presented at: Association for Molecular Pathology 2017 Annual Meeting. 2017 November 16-18, Salt Lake City, UT, USA. Multiple Highly Concordant Assays Facilitate Analyses of Clinical Samples at Different Scales and Sensitivities Poster presented at: Association for Molecular Pathology 2017 Annual Meeting. 2017 November 16-18, Salt Lake City, UT, USA. Detection of Clonal TRG and TRB Gene Rearrangements Using Next-Generation Sequencing Poster presented at: Association for Molecular Pathology 2017 Annual Meeting. 2017 November 16-18, Salt Lake City, UT, USA. Analysis and Characterization of Hematologic Cancers Using a Comprehensive NGS Panel Comprised of DNA and RNA Baits Targeting 704 Genes Poster presented at: 22nd Congress of the European Hematology Association. 2017 June 22-25. Madrid, Spain. Next Generation Sequencing Targeted Panel for Minimal Residual Disease Monitoring in Acute Myeloid Leukemia Poster presented at: 22nd Congress of the European Hematology Association. 2017 June 22-25. Madrid, Spain. Detection of Clonality in Clinical Specimens from Suspected B-Cell Malignancies Using Comprehensive IGH Lymphotrack® MiSeq® and PGM® Assays Poster presented at: 22nd Congress of the European Hematology Association. 2017 June 22-25. Madrid, Spain. Small Customizable NGS Based Target Capture Panels Detect Variants in Clinical Specimens at Frequencies as Low as 0.5% Poster presented at: 22nd Congress of the European Hematology Association. 2017 June 22-25. Madrid, Spain. Detecting B-Cell Clonality in Clinical Samples using a Comprehensive NGS LymphoTrack Dx® IGH FR1/2/3 Assay Poster presented at: Association for Molecular Pathology Global 2017 Meeting. 2017 April 3-5. Berlin, Germany. Assessment of Minimal Residual Disease in Patients with Acute Myeloid Leukemia by Monitoring FLT3 and NPM1 Mutations Poster presented at: Association for Molecular Pathology Global 2017 Meeting. 2017 April 3-5. Berlin, Germany. A Precision Medicine Approach Incorporating Both Molecular and In Vitro Functional Data to Treat Patients with Relapsed/Refractory Acute Myeloid Leukemia Poster Presented at: 58th Annual American Society for Hematology Meeting. 2016 Dec. 3-6. San Diego, CA, USA. Precision Medicine Assays Detect Novel Targetable FLT3 Fusions Amenable to Therapeutic Intervention in a Patient with Refractory Acute Myeloid Leukemia Poster Presented at: 58th Annual American Society for Hematology Meeting. 2016 Dec. 3-6. San Diego, CA, USA. Next-Generation Sequencing of FLT3/ITD for Minimal Residual Disease Monitoring in Leukemia Patients Poster Presented at: Association for Molecular Pathology 2016 Annual Meeting. November 10-12, 2016 at the Charlotte Convention Center in Charlotte, NC, USA. Next-Generation Sequencing of NPM1 for Minimal Residual Disease Monitoring in Leukemia Patients Poster Presented at: Association for Molecular Pathology 2016 Annual Meeting. November 10-12, 2016 at the Charlotte Convention Center in Charlotte, NC, USA. Detection of Clonal Immunoglobulin and T-Cell Receptor Gene Rearrangements in Acute Myeloid Leukemia Poster Presented at: Association for Molecular Pathology 2016 Annual Meeting. November 10-12, 2016 at the Charlotte Convention Center in Charlotte, NC, USA. *For copies of our recent posters, please email us at marketing@invivoscribe.com or visit our website at www.invivoscribe.com Development of a Comprehensive IGH NGS Assay for Detecting Suspected B-Cell Clonality Poster Presented at: Association for Molecular Pathology 2016 Annual Meeting. November 10-12, 2016 at the Charlotte Convention Center in Charlotte, NC, USA. Detection of Minimal Residual Disease in FLT3/ITD AML Poster presented at: American Society of Clinical Oncology 2016 Annual Meeting. June 3-7, 2016 at McCormick Place in Chicago, Illinois, USA. Development of LymphoTrack® Bioinformatics Methods: Clonality Testing, Somatic Hypermutation, and Minimal Residual Disease Poster Presented at: Association for Molecular Pathology 2015 Annual Meeting. 2015 Nov 4-8. Austin, TX, USA. Detection of Clonal TRG Gene Rearrangements Shows Improved Sensitivity and Positive Predictive Value Compared to Fragment Analysis Using BIOMED-2 Primers and Capillary Electrophoresis Poster Presented at: Association for Molecular Pathology 2015 Annual Meeting. 2015 Nov 4-8. Austin, TX, USA. Development of an NGS Assay for IGK that can be Combined with IGH for Identifying Clonal Populations in Lymphoid Malignancies Poster Presented at: 20th Congress of the European Hematology Association. 2015 June 11-14. Vienna, Austria. Clinical Assessment of Chronic Lymphocytic Leukemia (CLL) samples for Somatic Hypermutation Status by Next-Generation Sequencing and Sanger Sequencing Poster Presented at: 20th Congress of the European Hematology Association. 2015 June 11-14. Vienna, Austria. Somatic Hypermutation and V-J Gene Usage for CLL Prognosis: Evaluating Data from MiSeq® NGS vs. PCR-Sanger Sequencing Approaches Poster Presented at: 56th Annual American Society for Hematology Meeting. 2014 Dec. 6-9. San Francisco, CA, USA. International Validation of a Harmonized NGS PGM™ Assay at Clinical Labs in the US and the EU Poster Presented at: Association for Molecular Pathology 2014 Annual Meeting. 2014 Nov 13-15. National Harbor, MD, USA. Performance of an IGH Somatic Hypermutation Assay with Associated LymphoTrack® Bioinformatics Developed for the MiSeq® NGS Platform Poster Presented at: 19th Congress of the European Hematology Association. 2014 June 12-15. Milan, Italy. Concordance in IGH & TRG Clonality Testing: Comparison of Data Generated Using the MiSeq® & PGMTM Platforms Poster Presented at: 19th Congress of the European Hematology Association. 2014 June 12-15. Milan, Italy. Combined TRG and IGH Clonality Testing on the PGMTM Using LymphoTrack® Reagents & Bioinformatics Poster Presented at: 19th Congress of the European Hematology Association. 2014 June 12-15. Milan, Italy. Identifying and Monitoring IGH Clonality Using Massively Parallel Sequencing and Associated Bioinformatics Poster Presented at: Association for Molecular Pathology 2013 Annual Meeting. 2013 Nov. 15-16. Phoenix, AZ, USA. Detecting Minimal Residual Disease Using a Massively Parallel Sequencing TCRG Assay Poster Presented at: Association for Molecular Pathology 2013 Annual Meeting. 2013 Nov. 15-16. Phoenix, AZ, USA. Identifying and Monitoring TCRG Clonality Using Massively Parallel Sequencing and Associated Bioinformatics Poster Presented at: 18th Congress of the European Hematology Association. 2013 June 13-16. Stockholm, Sweden. Minimal Residual Disease in AML can be Monitored Utilizing Cell-Free DNA Poster Presented at: Association of Molecular Pathology 2018 Annual Meeting. 2018 Nov. 1-3. San Antonio, TX, USA. Detection of Clonal Rearrangements in Multiple Myeloma Sample using LymphoTrack® Assays Poster Presented at: Association of Molecular Pathology 2018 Annual Meeting. 2018 Nov. 1-3. San Antonio, TX, USA.